Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

de Frutos Porras, E; Cobo-Vázquez, E; Lobo, AH; del Mar Santos Sebastián, M; Fernández, EP; Colino, CG; Cela, E; Gómez, MLN.

A Local Experience of Antibiotic Lock Therapy as an Adjunctive Treatment for Central Venous Catheter-Related Bloodstream Infections in Pediatric Oncology and Hematology Patients

Children-Basel. 2024; 11(8): Nº de citas: 1 [doi:10.3390/children11080983]

Spanjaart, AM; Ljungman, P; Tridello, G; Schwartz, J; Martinez-Cibrian, N; Barba, P; Kwon, M; Lopez-Corral, L; Martinez-Lopez, J; Ferra, C; Di Blasi, R; Ghesquieres, H; Mutsaers, P; Calkoen, F; Jak, M; van Doesum, J; Vermaat, JSP; van der Poel, M; Maertens, J; Gambella, M; Metafuni, E; Ciceri, F; Saccardi, R; Nicholson, E; Tholouli, E; Matthew, C; Potter, V; Bloor, A; Besley, C; Roddie, C; Wilson, K; Nagler, A; Campos, A; Petersen, SL; Folber, F; Bader, P; Finke, J; Kroger, N; Knelange, N; de la Camara, R; Kersten, MJ; Mielke, S.

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

LEUKEMIA. 2024; 38(9): 1985-1991 Nº de citas: 4 [doi:10.1038/s41375-024-02336-1]

Bug, G; Labopin, M; Kulagin, A; Blaise, D; Raiola, AM; Vydra, J; Sica, S; Kwon, M; López-Corral, L; Bramanti, S; Borne, PV; Itälä-Remes, M; Martino, M; Koc, Y; Brissot, E; Giebel, S; Nagler, A; Ciceri, F; Mohty, M.

Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)

BONE MARROW TRANSPLANTATION. 2024; 59(10): 1394-1401 [doi:10.1038/s41409-024-02331-1]

Iacoboni, G; Sánchez-Salinas, MA; Rejeski, K; Martín-López, AA; Kwon, M; Navarro, V; Jalowiec, KA; Hernani, R; Reguera-Ortega, JL; Gallur, L; Blumenberg, V; Herrero-García, M; Roddie, C; Benzaquén, A; Delgado-Serrano, J; Bailén, R; Carpio, C; Amat, P; López-Corral, L; Martín-Martín, L; Bastos, M; Subklewe, M; O'Reilly, M; Barba, P.

Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells

Hemasphere. 2024; 8(7): Nº de citas: 3 [doi:10.1002/hem3.86]

van Besien, K; Liu, HT; Margevicius, S; Fu, PF; Artz, A; Chaekal, OK; Metheny, L; Shore, T; Kosuri, S; Mayer, S; Gomez-Arteaga, A; Kwon, M.

Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes

LEUKEMIA & LYMPHOMA. 2024; 65(10): 1384-1397 Nº de citas: 1 [doi:10.1080/10428194.2024.2361353]

Fox, ML; García-Cadenas, I; Navarro, V; Martínez, AP; Kara, M; Bazán, IS; Coll, CF; Bailén, R; Bento, L; Parody, R; Esquirol, A; Orti, G; Mussetti, A; Salamero, O; Martino, R; González, AP; Barba, P; Kwon, M; Solano, C; Bosch, F; Valcárcel, D.

Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies

BONE MARROW TRANSPLANTATION. 2024; 59(10): 1369-1375 [doi:10.1038/s41409-024-02322-2]

Puyó, PV; Tagarro, A; Garcia-Obregon, S; Bejarano, OV; Moraleda, C; Aragonés, JH; Cancho, EJB; Morros, AF; Galán-Gómez, V; Fernández, LE; Lendinez-Molinos, F; Velasco, BH; Horno, LU; Domínguez-Pinilla, N; Gazquez, JFP; Lozano, CN; Osuna-Marco, M; Marín-Cruz, I; Pastrana, IG; Barandiaran, NGD; Mingo, NG; Rodríguez, RP; Cañete, A; León, MP; Bustamante, SC; Garcíia, MT; Gonzalez-Prieto, A; Solé-Rodríguez, M; Cruz, MG; Soriano-Arandes, A; Mota, M; Pérez-Hoyos, S; Moreno, L; Astigarraga, I.

Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

PEDIATRIC BLOOD & CANCER. 2024; 71(8): [doi:10.1002/pbc.31120]

Huerga, RN; de Diego, IS; Jiménez, CD; Martínez, CM; Kwon, M; García, NP; Calbacho, M; Vicente, AR; Gallardo, PS.

Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective

EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2024; 70: Nº de citas: 1 [doi:10.1016/j.ejon.2024.102584]

Carabante, MIB; Bueno, D; García, LA; Torija, IL; Marsal, J; Navarro, JMF; Oficialdegui, MLU; Panesso, M; Molina, B; Bieler, CB; Palomo, P; Martinez, AP; Diaz-de-Heredia, C.

Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

Transplantation And Cellular Therapy. 2024; 30(6): Nº de citas: 6 [doi:10.1016/j.jtct.2024.03.019]

Salgado, M; Gálvez, C; Nijhuis, M; Kwon, M; Cardozo-Ojeda, EF; Badiola, J; Gorman, MJ; Huyveneers, LEP; Urrea, V; Bandera, A; Jensen, BEO; Vandekerckhove, L; Jurado, M; Raj, K; Wiesch, JSZ; Bailen, R; Eberhard, JM; Nabergoj, M; Hütter, G; Saldaña-Moreno, R; Oldford, S; Barrett, L; Ramirez, MLM; Garba, S; Gupta, RK; Revollo, B; Ferra-Coll, C; Kuball, J; Alter, G; Sáez-Cirión, A; Diez-Martin, JL; Duke, ER; Schiffer, JT; Wensing, A; Martinez-Picado, J.

Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study

Lancet HIV. 2024; 11(6): 389-405 Nº de citas: 1 [doi:10.1016/S2352-3018(24)00090-0]

Lakhwani S; Rosiñol L; Puig N; Pico-Picos MA; Medina-González L; Martínez-López J; Paiva B; Cedena MT; Oriol A; Ríos-Tamayo R; Blanchard MJ; Jarque I; Bargay J; Moraleda JM; Carrillo-Cruz E; Sureda A; Krsnik I; González E; Casado LF; Martí JM; Encinas C; De Arriba F; Palomera L; Sampol A; González-Montes Y; Motlló C; De La Cruz J; Alonso R; Mateos MV; Bladé J; Lahuerta JJ; San-Miguel J; Hernández MT.

Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.

HAEMATOLOGICA. 2024; 109(6): 1909-1917 Nº de citas: 4 [doi:10.3324/haematol.2023.284154]

Giménez, Y; Palacios, M; Sanchez-Domínguez, R; Zorbas, C; Peral, J; Puzik, A; Ugalde, L; Alberquilla, O; Villanueva, M; Rio, P; Gálvez, E; Da Costa, L; Strullu, M; Catala, A; Ruiz-Llobet, A; Segovia, JC; Strahm, B; Niemeyer, CM; Belendez, C; Leblanc, T; Lafontaine, DLJ; Bueren, J; Navarro, S.

Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia

Jci Insight. 2024; 9(10): Nº de citas: 4 [doi:10.1172/jci.insight.171650]

Sánchez, JMM; Cancho, EJB; Benéitez, D; Payán-Pernía, S; Gimbert, AC; Ruiz-Llobet, A; Salinas, JA; Sebastián, E; Argilés, B; Bermúdez, M; Vázquez, MA; Ortega, MJ; Rubio, ML; Gondra, A; Uriz, JJ; Morado, M; Coll, MT; Duarte, ML; Baro, M; Cervera, A; Recasens, V; Blanes, CG; del Carcavilla, MP; Tallon, M; Espín, AG; Olteanu, FCO; González, P; Pereira, MMD; Cela, E.

Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)

ANNALS OF HEMATOLOGY. 2024; 103(8): 2743-2755 Nº de citas: 2 [doi:10.1007/s00277-024-05788-8]

Bazarbachi, AH; Labopin, M; Raiola, AM; Blaise, D; Arcese, W; Santarone, S; Koc, Y; Bramanti, S; Kulagin, A; Kwon, M; Sica, S; Sanz, J; Brissot, E; Nagler, A; Ciceri, F; Mohty, M.

Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

CANCER. 2024; 130(18): 3123-3136 Nº de citas: 6 [doi:10.1002/cncr.35365]

Stock, CNT; Chillón, CJ; Moro, FM; Palomanes, JM; Villaespesa, MP; Santiago, ER; Martín, ER; Rodríguez, AC; Gutiérrez, VG; Jiménez, GM; Jiménez, JL; Puente, PH.

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

Frontiers in Oncology. 2024; 14: Nº de citas: 1 [doi:10.3389/fonc.2024.1394648]

Wlodarski, MW; Vlachos, A; Farrar, JE; Da Costa, LM; Kattamis, A; Dianzani, I; Belendez, C; Unal, S; Tamary, H; Pasauliene, R; Pospisilova, D; de la Fuente, J; Iskander, D; Wolfe, L; Liu, JM; Shimamura, A; Albrecht, K; Lausen, B; Bechensteen, AG; Tedgard, U; Puzik, A; Quarello, P; Ramenghi, U; Bartels, M; Hengartner, H; Farah, RA; Al Saleh, M; Hamidieh, AA; Yang, W; Ito, E; Kook, H; Ovsyannikova, G; Kager, L; Gleizes, PE; Dalle, JH; Strahm, B; Niemeyer, CM; Lipton, JM; Leblanc, TM.

Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement

Lancet Haematology. 2024; 11(5): 368-382

Iacoboni, G; Iraola-Truchuelo, J; O'Reilly, M; Navarro, V; Menne, T; Kwon, M; Martin-Lopez, AA; Chaganti, S; Delgado, J; Roddie, C; Perez, A; Norman, J; Guerreiro, M; Gibb, A; Caballero, AC; Besley, C; Martinez-Cibrian, N; Mussetti, A; Sanderson, R; Luzardo, H; Iyengar, S; Sanchez, JM; Jones, C; Sancho, JM; Barba, P; Latif, AL; Lopez-Corral, L; Hernani, R; Reguera, JL; Sureda, A; Garcia-Sancho, AM; Bastos, M; Abrisqueta, P; Kuhnl, A.

Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy

Hemasphere. 2024; 8(5): [doi:10.1002/hem3.62]

Ríos-Tamayo, R; Lecumberri, R; Cibeira, MT; González-Calle, V; Alonso, R; Domingo-González, A; Landete, E; Encinas, C; Iñigo, B; Blanchard, MJ; Alejo, E; Krsnik, I; Gómez-Bueno, M; Garcia-Pavia, P; Segovia-Cubero, J; Rosiñol, L; Lahuerta, JJ; Martínez-López, J; Bladé, J.

A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis

Cancers. 2024; 16(9): Nº de citas: 3 [doi:10.3390/cancers16091689]